Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

190.41 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Quest (DGX) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Quest (NYSE:DGX) Surprises With Q2 Sales
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) announced better-than-expected revenue in Q2 CY2025, with sales up 15.2% year on year to $2.76 billion. The company’s full-year revenue... 
Via StockStory
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Quest (DGX) Reports Q2: Everything You Need To Know Ahead Of Earnings
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) will be reporting earnings this Tuesday morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence World Trade
Where Quest Diagnostics Stands With Analysts
 
Via Benzinga
Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years
 
Via Benzinga
Earnings Scheduled For July 22, 2025
 
Via Benzinga
Quest Diagnostics Earnings Preview
 
Via Benzinga
QUEST DIAGNOSTICS INC (NYSE:DGX) - A Reliable Dividend Stock With Strong Fundamentals
QUEST DIAGNOSTICS INC (NYSE:DGX) offers a reliable dividend with steady growth, strong profitability, and sound financial health, making it a compelling choice for income investors. 
Via Chartmill
1 Mid-Cap Stock with Competitive Advantages and 2 to Brush Off
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
Motley Fool Investors Look Back at the First Half of 2025
Via The Motley Fool
Topics Government World Trade
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out
BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and Exact Sciences. 
Via Benzinga
Topics Artificial Intelligence
QUEST DIAGNOSTICS INC (NYSE:DGX) – A Reliable Dividend Stock Worth Considering
QUEST DIAGNOSTICS INC (NYSE:DGX) offers a reliable dividend with strong profitability and financial health, making it a solid pick for income investors. 
Via Chartmill
Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years
 
Via Benzinga
1 Safe-and-Steady Stock to Own for Decades and 2 to Avoid
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
1 S&P 500 Stock to Consider Right Now and 2 to Steer Clear Of
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
Testing & Diagnostics Services Stocks Q1 Teardown: Quest (NYSE:DGX) Vs The Rest
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the testing & diagnostics services industry, including Quest (NYSE:DGX) and its peers. 
Via StockStory
QUEST DIAGNOSTICS INC (NYSE:DGX) – A Reliable Dividend Stock Worth Considering
QUEST DIAGNOSTICS INC (NYSE:DGX) offers reliable dividend growth, strong profitability, and reasonable valuation, making it a compelling choice for income investors. 
Via Chartmill
QUEST DIAGNOSTICS INC (NYSE:DGX) – A Strong Technical Setup for Breakout Traders
QUEST DIAGNOSTICS (NYSE:DGX) shows strong technicals with a perfect 10 rating and a high-quality breakout setup, making it a candidate for traders watching for upside momentum. 
Via Chartmill
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
1 Cash-Producing Stock to Own for Decades and 2 to Brush Off
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
DGX Q1 Earnings Call: Acquisitions, Advanced Diagnostics, and Operational Initiatives Drive Growth
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 12.1% year on year to $2.65 billion. The company... 
Via StockStory
Topics Artificial Intelligence World Trade
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
3 Mid-Cap Stocks with Mounting Challenges
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
Via StockStory
Is QUEST DIAGNOSTICS INC (NYSE:DGX) a Good Fit for Dividend Investing?
Why the dividend investor may take a look at QUEST DIAGNOSTICS INC (NYSE:DGX). 
Via Chartmill
Guardant Health (GH) Q1 Earnings Report Preview: What To Look For
Diagnostics company Guardant Health (NASDAQ:GH) will be reporting earnings tomorrow after market hours. Here’s what you need to know. 
Via StockStory
Topics World Trade
Labcorp (LH) Reports Q1: Everything You Need To Know Ahead Of Earnings
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be announcing earnings results tomorrow before market open. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting earnings tomorrow morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence World Trade
QUEST DIAGNOSTICS INC (NYSE:DGX) Shows Potential for a Breakout.
The technical analysis for QUEST DIAGNOSTICS INC (NYSE:DGX) is highly positive, with a rating of 9 out of 10, suggesting a potential breakout. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.